Trump's Weight Loss Drug Deals Spark Controversy Over Costs and Coverage

The Trump administration is implementing policies to combat obesity by making weight-loss drugs more affordable through negotiated prices and copays, while also proposing bans on soda and candy purchases with SNAP benefits in several states, aiming to reduce 'disease fuel' consumption and promote healthier choices, though critics argue these measures may undermine dignity and autonomy and face practical challenges.